KalVista Pharmaceuticals, Inc. (Nasdaq: KALV) today announced that five abstracts, including one late-breaking submission, have been accepted for presentation at the 2026 Global Angioedema Leadership ...

D3 Bio Inc, a global clinical-stage biotechnology company focused on developing transformative oncology therapeutics, is ...

Preclinical data on Caliway's fat reduction drug candidate CBL-514 in combination with GLP-1R-based weight-loss therapies has been selected for oral ...

AL-S Pharma AG, a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic lateral sclerosis (ALS), today announced the ...

Zymeworks Inc. (Nasdaq: ZYME), a biotechnology company managing a portfolio of licensed healthcare assets while developing a diverse pipeline of novel, multifunctional biotherapeutics, today announced ...

A newly released video from former Pentagon and White House Advisor Jim Rickards is raising concerns about the shaky economic foundation behind the fast-growing artificial intelligence boom. The ...

Collaboration, Innovation, and Trust: techUK at the UN Global Fraud Summit . techUK was proud to represent the UK technology sector at the in ...

Best AI tools for finance research and presentations, including Claude in Excel and Claude in PowerPoint, with accuracy ...

Reinventing AI Strategy for 2026 March 18, 2026 11:00 AM EDTCompany ParticipantsJustine IversonJESSE KRAMER - Head of ...

The Goldman Sachs Large Cap Value Fund underperformed in Q4 2025 despite gains from Alphabet and Caterpillar. Read the full ...

Four presentations deliver new insights into zanidatamab, including its differentiated HER2 biologyVANCOUVER, British Columbia, March 18, 2026 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a biot ...

Global eCommerce growth is no longer defined solely by logistics, pricing, or competition. As digital commerce expands across regions, languages, and consumer s ...